01406nam 2200361 450 991067403480332120230626210537.0(CKB)5400000000044483(NjHacI)995400000000044483(EXLCZ)99540000000004448320230626d2022 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierImmunotherapy in Myeloma A Theme Issue in Honor of Prof. Dr. Gösta Gahrton /Nicolaus Kröger, Laurent GarderetBasel :MDPI - Multidisciplinary Digital Publishing Institute,2022.1 online resource (124 pages)3-0365-2906-3 Immunotherapy in multiple myeloma, first investigated with allogeneic stem cell transplantation, is now a major pillar in the treatment of multiple myeloma. CAR-T-cell technology, monoclonal or bispecific antibodies, as well as new forms of cellular therapy, have revolutionized the treatment of this hematological malignancy.Immunotherapy in Myeloma MedicineMedicine.610Kröger Nicolaus1214304Garderet LaurentNjHacINjHaclBOOK9910674034803321Immunotherapy in Myeloma3390841UNINA